Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds

Boron Neutron Capture Therapy is a re-emerging therapy for the treatment of cancer, and the development of new neutron-reactive nuclei carriers with enhanced efficiency is of great importance. In this work we propose three new boron-based solid compounds, of formulas [Ca(H<sub>2</sub>O)&...

Full description

Saved in:
Bibliographic Details
Main Authors: Domenica Marabello, Paola Benzi, Carlo Canepa, Alma Cioci
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Inorganics
Subjects:
Online Access:https://www.mdpi.com/2304-6740/13/5/136
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849711509046820864
author Domenica Marabello
Paola Benzi
Carlo Canepa
Alma Cioci
author_facet Domenica Marabello
Paola Benzi
Carlo Canepa
Alma Cioci
author_sort Domenica Marabello
collection DOAJ
description Boron Neutron Capture Therapy is a re-emerging therapy for the treatment of cancer, and the development of new neutron-reactive nuclei carriers with enhanced efficiency is of great importance. In this work we propose three new boron-based solid compounds, of formulas [Ca(H<sub>2</sub>O)<sub>6</sub>](C<sub>14</sub>H<sub>8</sub>O<sub>6</sub>B)<sub>2</sub> (CaSB), [Cu(C<sub>14</sub>H<sub>8</sub>O<sub>6</sub>B)] (CuSB), and [Li(C<sub>14</sub>H<sub>8</sub>O<sub>6</sub>B)(H<sub>2</sub>O)] (LiSB), usable as nanoparticles for the carriage of the <sup>10</sup>B isotope. The copper atom in CuSB was introduced because it is known that its presence magnifies the effect of the radiation on cells. Furthermore, the lithium atom in LiSB also allows us to include the <sup>6</sup>Li isotope, which can take part in the nuclear reactions, enhancing the efficiency of the anti-cancer treatment. The compounds were characterized with single-crystal X-ray diffraction to compare the densities of the reactive isotopes in the materials, a key parameter related to the efficiency of the materials. In this work, we used a computational method to calculate the dose absorbed by a tumor mass treated with nanoparticles of the compounds in order to select the most efficient one for the therapy. The results reported in this work are encouraging.
format Article
id doaj-art-9785263f6e8245ab99bcda37c70907cd
institution DOAJ
issn 2304-6740
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Inorganics
spelling doaj-art-9785263f6e8245ab99bcda37c70907cd2025-08-20T03:14:36ZengMDPI AGInorganics2304-67402025-04-0113513610.3390/inorganics13050136Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising CompoundsDomenica Marabello0Paola Benzi1Carlo Canepa2Alma Cioci3Dipartimento di Chimica, Università degli Studi di Torino, 10125 Torino, ItalyDipartimento di Chimica, Università degli Studi di Torino, 10125 Torino, ItalyDipartimento di Chimica, Università degli Studi di Torino, 10125 Torino, ItalyDipartimento di Chimica, Università degli Studi di Torino, 10125 Torino, ItalyBoron Neutron Capture Therapy is a re-emerging therapy for the treatment of cancer, and the development of new neutron-reactive nuclei carriers with enhanced efficiency is of great importance. In this work we propose three new boron-based solid compounds, of formulas [Ca(H<sub>2</sub>O)<sub>6</sub>](C<sub>14</sub>H<sub>8</sub>O<sub>6</sub>B)<sub>2</sub> (CaSB), [Cu(C<sub>14</sub>H<sub>8</sub>O<sub>6</sub>B)] (CuSB), and [Li(C<sub>14</sub>H<sub>8</sub>O<sub>6</sub>B)(H<sub>2</sub>O)] (LiSB), usable as nanoparticles for the carriage of the <sup>10</sup>B isotope. The copper atom in CuSB was introduced because it is known that its presence magnifies the effect of the radiation on cells. Furthermore, the lithium atom in LiSB also allows us to include the <sup>6</sup>Li isotope, which can take part in the nuclear reactions, enhancing the efficiency of the anti-cancer treatment. The compounds were characterized with single-crystal X-ray diffraction to compare the densities of the reactive isotopes in the materials, a key parameter related to the efficiency of the materials. In this work, we used a computational method to calculate the dose absorbed by a tumor mass treated with nanoparticles of the compounds in order to select the most efficient one for the therapy. The results reported in this work are encouraging.https://www.mdpi.com/2304-6740/13/5/136salicylatoborate compoundsNeutron Capture Therapynanoparticlesabsorbed doseX-ray diffractionanti-cancer treatment
spellingShingle Domenica Marabello
Paola Benzi
Carlo Canepa
Alma Cioci
Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds
Inorganics
salicylatoborate compounds
Neutron Capture Therapy
nanoparticles
absorbed dose
X-ray diffraction
anti-cancer treatment
title Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds
title_full Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds
title_fullStr Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds
title_full_unstemmed Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds
title_short Ca-, Li-, and Cu-Salicylatoborates for Potential Applications in Neutron Capture Therapy: A Computational Method for the Preliminary Discrimination of the More Promising Compounds
title_sort ca li and cu salicylatoborates for potential applications in neutron capture therapy a computational method for the preliminary discrimination of the more promising compounds
topic salicylatoborate compounds
Neutron Capture Therapy
nanoparticles
absorbed dose
X-ray diffraction
anti-cancer treatment
url https://www.mdpi.com/2304-6740/13/5/136
work_keys_str_mv AT domenicamarabello caliandcusalicylatoboratesforpotentialapplicationsinneutroncapturetherapyacomputationalmethodforthepreliminarydiscriminationofthemorepromisingcompounds
AT paolabenzi caliandcusalicylatoboratesforpotentialapplicationsinneutroncapturetherapyacomputationalmethodforthepreliminarydiscriminationofthemorepromisingcompounds
AT carlocanepa caliandcusalicylatoboratesforpotentialapplicationsinneutroncapturetherapyacomputationalmethodforthepreliminarydiscriminationofthemorepromisingcompounds
AT almacioci caliandcusalicylatoboratesforpotentialapplicationsinneutroncapturetherapyacomputationalmethodforthepreliminarydiscriminationofthemorepromisingcompounds